⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

Sanofi ADR (SNYN)

Mexico
Currency in MXN
979.50
0.00(0.00%)
Closed

SNYN Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa37,63137,36939,17545,38946,033
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+5.48%-0.7%+4.83%+15.86%+1.42%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa11,97612,10612,25113,69214,216
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa25,65525,26326,92431,69731,817
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+5.33%-1.53%+6.57%+17.73%+0.38%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa68.18%67.6%68.73%69.83%69.12%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa18,85317,68418,35920,65922,615
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+2.84%-6.2%+3.82%+12.53%+9.47%
aa.aaaa.aaaa.aaaa.aaaa.aa6,0205,5305,6926,7066,728
aa.aaaa.aaaa.aaaa.aaaa.aa9,9679,4489,59910,53910,765
aa.aaaa.aaaa.aaaa.aaaa.aa7201,0251,4881,5872,950
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa6,8027,5798,56511,0389,202
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+12.92%+11.42%+13.01%+28.87%-16.63%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa18.08%20.28%21.86%24.32%19.99%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-453-422-359-22119
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-13.53%+6.84%+14.93%+38.44%+108.6%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-544-459-362-394-527
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa91373173546
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa492497111101-782
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa6,8417,6548,31710,9188,439
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa296443418655688
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-3,039-206-77255-578
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa3,00714,1377,83710,4907,038
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-38.68%+370.14%-44.56%+33.85%-32.91%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa7.99%37.83%20.01%23.11%15.29%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1211,8071,5582,0061,602
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa2,78512,3306,2798,4845,436
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-31-36-56-113-36
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa2,75412,2946,2238,3715,400
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-36.04%+346.41%-49.38%+34.52%-35.49%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa7.32%32.9%15.89%18.44%11.73%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa2,85512,2946,2238,3715,400
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa2.289.814.976.694.31
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-34.04%+329.34%-49.34%+34.58%-35.48%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa2.279.764.956.664.3
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-34.01%+329.96%-49.28%+34.55%-35.44%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,249.91,253.61,252.51,251.91,251.7
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,257.11,260.11,257.91,256.91,256.4
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa3.153.23.333.563.76
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+2.61%+1.59%+4.06%+6.91%+5.62%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa10,11310,46611,25114,06212,520
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+8.01%+3.49%+7.5%+24.98%-10.97%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa26.87%